Tumor mutation burden-assisted risk stratification for papillary thyroid cancer.

Zhijiang ChenWeiran WangJiajie XuYuntao SongHonglin ZhuTonghui MaMinghua GeHaixia Guan

Published in: Endocrine (2022)

The presence of BRAF V600E and/or TERT promoter mutations denotes a high risk of recurrence in TMB-H patients. This represents a powerful molecular prognostic genotype that can help predict patients with the highest risk of recurrence.

Keyphrases

papillary thyroid
lymph node metastasis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
dna methylation
gene expression
prognostic factors
transcription factor
risk factors
free survival
patient reported outcomes
single molecule
patient reported